Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

China flag China · Delayed Price · Currency is CNY
22.24
-0.59 (-2.58%)
Jul 30, 2026, 3:04 PM CST
Market Cap1.68B -34.5%
Revenue (ttm)238.55M -1.4%
Net Income22.79M -34.0%
EPS0.30 -33.7%
Shares Out 75.49M
PE Ratio74.64
Forward PEn/a
Dividend0.15 (0.64%)
Ex-Dividend DateJun 1, 2026
Volume2,001,500
Open22.65
Previous Close22.83
Day's Range21.91 - 23.12
52-Week Range21.88 - 36.98
Beta0.47
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:301130

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anti-anemia, mental disorders, circulatory disorders, anti-psychotic, active pharmaceutical ingredients, and antidepressant medication. It also provides iron supplements and blood tonics; psychotropic drugs; cardiovascular system medication; medication for chronic diseases in the elderly; cancer adjuvant dr... [Read more]

Sector Healthcare
Founded 1990
Employees 313
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301130
Full Company Profile

Financial Performance

In 2025, SHE:301130's revenue was 234.84 million, a decrease of -8.41% compared to the previous year's 256.41 million. Earnings were 21.90 million, a decrease of -45.62%.

Financial Statements